2018 Biotechnology Awards

GHP / Biotechnology Awards 2018 19 osteoporosis, macular degeneration, glaucoma, food intolerance and some other frequent health problems. These tests are used in preventive medicine to provide a personalized prevention approach. They are available through physicians, alternative practitioners, pharmacists, and other healthcare providers. Personalized medicine can add tremendous value to the healthcare system. It provides an innovative approach to disease prevention and treatment that takes into account differences in patient’s genes, environments and lifestyle. More than 10 years ago Bioglobe became interested in pharmacogenomics. The ultimate goal is to understand how the genetic makeup determines drug action and adverse reactions. A co-operation has started between Professor Dragan Primorac from St. Catherine Hospital, a private hospital in Croatia (member of the leading hospitals of the world) and Bioglobe. The clinic wants to provide a genetic test to every patient covering the most important gene variants involved in drug response. A geriatric clinic, which will open up this year in Berlin, has mandated Bioglobe to develop a concept for pharmacogenetic testing of their patients in order to reduce the problem of polypharmacy in elderly people. Additionally, Bioglobe also develops personalized concepts for lifestyle issues. Dermasciance™ is a personalized anti-aging concept based on a genetic profile assessing the predisposition for skin aging. Genes involved in the capacity to repel aggressive radicals, the capacity for detoxification of harmful substances and the capacity for regeneration of skin structure are analyzed. In order to support the three important biological processes, Bioglobe has developed serums with concentrated dermato-cosmetic active ingredients which ensure specific support of the processes debilitated. One of the most exciting projects Bioglobe is involved in started in 2014. Professor Hoeppner was appointed to help to develop a concept for genetic identification of hundreds of thousands of victims of the Vietnam War for the government of Vietnam. This is the largest identification project of all times and intends to recover the victims of the Vietnam War from mass graves, genetically identify and hand the remains of victims over to their families so that they can be honored and buried in accordance with the culture. After about two years of project planning and several meetings with the experts from laboratories involved in Vietnam as well as with anthropologists and forensic scientists from the USA, Korea and the Netherlands in Hanoi, Bioglobe signed a consultancy and technology transfer contract for the extensive project. Overall, this ongoing co-operation between Bioglobe and the Institute of Biotechnology IBT at the Vietnam Academy of Science and Technology has now led to the implementation of a DNA laboratory with highest technical standard in Hanoi. Bioglobe will support the genotyping work with implementing cutting edge genotyping technology offering it even more opportunities to build upon its current success. Company: Bioglobe GmbH Contact: Wolfgang Höppner Address: Grandweg 64, DE 22529, Hamburg, Germany Phone: 0049 40 429 346 0 Website: http://bioglobe.net/ Scientists from Vietnam during the DNA training at Bioglobe Senator Katarina Fegebank, Prof. Hoeppner (left) and